Evidence map›Paper›PMID 42213284›Full record

ArticleHead and neck pathology2026

Correction: Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation.

Grayson G Cole, Matt Levin, David Ferber, Spencer C Roark, Peter M Sadow, Daniel Lubin, Julie Guilmette, Jason R Pettus, Adam S Fisch, Dipti P Sajed and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Grayson G ColeDepartment of Pathology, University Hospitals, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-7409-0705
Matt LevinCell IDx, Inc. (A Division of Leica Biosystems), San Diego, CA, USA.
David FerberMedical & Scientific Affairs, Leica Biosystems, Deer Park, IL, USA.
Spencer C RoarkVanderbilt University Medical Center, Nashville, TN, USA.
Peter M SadowDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1036-6367
Daniel LubinEmory Healthcare, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-0409-2374
Julie GuilmetteHôpital Charles-Le Moyne, Québec, QC, USA.
Jason R PettusDartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Adam S FischDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4742-8165
Dipti P SajedDepartment of Pathology, University of California, Los Angeles, Los Angeles, CA, USA.
Fouad R ZakkaWellstar Health System, Atlanta, GA, USA.
Mark W LingenDepartment of Pathology, The University of Chicago, Chicago, IL, USA.
Nicole A CiprianiDepartment of Pathology, The University of Chicago, Chicago, IL, USA. Nicole.Cipriani@bsd.uchicago.edu.ORCID http://orcid.org/0000-0003-3092-2746

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42213284
PMCPMC13221555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.